skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

Review

(1909) Views  (725) Full article downloads

Authors: BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al

Published Date October 2010 Volume 2010:3 Pages 115 - 122
DOI: http://dx.doi.org/10.2147/IDR.S10743

BM Yashodhara1, Choo Beng Huat1, Lakshmi Nagappa Naik1, Shashikiran Umakanth2, Manjunatha Hande2, Joseph M Pappachan3
1Department of Medicine, Melaka Manipal Medical College, Melaka, India; 2Department of Medicine, Kasturaba Medical College, Manipal; 3Department of Medicine, Kottayam Medical College, Kerala, India

Abstract: Despite intensive efforts to eradicate the disease, tuberculosis continues to be a major threat to Indian society, with an estimated prevalence of 3.45 million cases in 2006. Emergence of multidrug-resistant tuberculosis has complicated eradication attempts in recent years. Incomplete and/inadequate treatment are the main causes for development of drug resistance. Directly observed therapy, short-course (DOTS) is the World Health Organization (WHO) strategy for worldwide eradication of tuberculosis, and our country achieved 100% coverage for DOTS through the Revised National Tuberculosis Control Program in 2006. For patients with multidrug-resistant tuberculosis, the WHO recommends a DOTS-Plus treatment strategy. Early detection and prompt treatment of multidrug-resistant tuberculosis is crucial to avoid spread of the disease and also because of the chances of development of potentially incurable extensively drug-resistant tuberculosis in these cases. This review discusses the epidemiologic, diagnostic, and therapeutic aspects of multidrug-resistant tuberculosis, and also outlines the role of primary care doctors in the management of this dangerous disease.

Keywords: multidrug-resistant, extensively drug-resistant, tuberculosis, general practice






Readers of this article also read:

New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Prevention strategies for antimicrobial resistance: a systematic review of the literature
The use of anti-tuberculosis therapy for latent TB infection
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Treatment of drug-resistant tuberculosis
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Drug-resistant tuberculosis: emerging treatment options
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University